Global Medical Affairs Director - Diagnostics, Lung

Accountabilities

• Global Diagnostic Strategy:
  Lead a unified diagnostics strategy for the lung portfolio, providing timely, high-quality input into global medical and lifecycle plans to deliver in-market companion diagnostics and testing solutions that enable optimal treatment selection and patient access.
• Strategic Partnerships:
  Build long-term, trust-based relationships with advocacy groups, scientific organizations, thought leaders, and HTA/payer bodies to shape best-in-class diagnostic capabilities aligned to portfolio medical needs.
• Diagnostics Medical Affairs Leadership:
  Direct all diagnostics-related Medical Affairs activities in collaboration with Tumor/Asset medical leaders, spanning scientific advisory boards, publications planning, evidence generation, diagnostic plan integration, and externally sponsored research and collaborations.
• Confidence Generation:
  Lead symposia, summits, and internal/external education to elevate diagnostic evidence and drive adoption of testing strategies among clinicians and health systems.
• Integration Across Assets:
  Embed diagnostic strategies in Tumor/Asset medical plans and provide diagnostics insights that inform broader strategy development and execution.
• Enterprise Contribution:
  Influence enterprise-level strategic planning to strengthen AstraZeneca’s leadership in medical diagnostics and shape future standards of care.
• Compliance Stewardship:
  Uphold AstraZeneca standards, SOPs, and external regulations across all medical and business activities.

• Lead global diagnostic strategy, ensuring timely, high-quality input into global medical and lifecycle plans to deliver in-market companion diagnostics and testing solutions that enable optimal treatment selection and patient access to the right therapies.
• Develop long-term, trust-based relationships with key external oncology stakeholders—advocacy groups, scientific organizations, thought leaders, and HTA/payer bodies—to shape best-in-class diagnostic capabilities aligned to portfolio medical needs.
• Provide leadership across all diagnostics-related Medical Affairs activities in collaboration with Tumor/Asset medical leaders, including scientific advisory boards, publications planning, evidence generation, diagnostic plan integration, and externally sponsored research and collaborations.
• Lead diagnostic confidence-generation initiatives—symposia, summits, and internal/external education—to accelerate understanding and adoption of testing strategies.
• Embed diagnostic strategies within Tumor/Asset medical plans and contribute diagnostics insights that inform the development and execution of broader Tumor/Asset strategies.
• Contribute to enterprise-level strategic planning to strengthen AstraZeneca’s leadership in medical diagnostics.
• Ensure all medical and business activities meet AstraZeneca standards, SOPs, and external regulations.

• Demonstrated impact advancing companion diagnostics in oncology, ideally including lung cancer biomarkers and testing pathways.
• Track record designing and executing medical evidence strategies that inform HTA/payer perspectives and clinical practice.
• Experience leading clinical and scientific advisory boards and integrating diagnostic publications within asset publication plans.
• Success guiding externally sponsored research and multi-center collaborations to address diagnostic adoption and access barriers.
• Ability to translate complex diagnostic science into clear, actionable education for diverse audiences across regions.
• Comfort operating globally and cross-functionally, engaging R&D, Commercial, Market Access, and external partners to deliver results.

The annual base pay for this position ranges from $193,282 - $289,922. Hourly and salaried non-exempt employees will also be paid overtime pay when working qualifying overtime hours. Base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience. In addition, our positions offer a short-term incentive bonus opportunity; eligibility to participate in our equity-based long-term incentive program (salaried roles),…